Different kinetics of obliterative airway disease development in heterotopic murine tracheal allografts induced by CD4+ and CD8+ T cells1
- 1 September 2002
- journal article
- research article
- Published by Wolters Kluwer Health in Transplantation
- Vol. 74 (5) , 646-651
- https://doi.org/10.1097/00007890-200209150-00010
Abstract
Background. Both T and B cells have been shown to be implicated in the pathogenesis of bronchiolitis obliterans syndrome, which is considered to represent chronic lung allograft rejection. However, the relative contributions of T cells and alloantibodies in the pathogenesis of the disease are still unknown. In this study, we used an heterotopic murine tracheal transplantation model to determine the contribution of these components of the immune system in the pathogenesis of posttransplant obliterative airway disease (OAD). Methods. Tracheal allografts from BALB/c and HLA-A2-transgenic (HLA-A2+) mice were heterotopically transplanted into C57BL/6, CD4-knockout (KO), CD8-KO, Ig-KO, and Rag1-KO mice. In additional experiments, recipient mice were pretreated with depleting antibodies against CD4+, CD8+, and NK1.1+ cells. Development of OAD was determined by histopathology at days 10, 30, 60, 90, and 180 after transplantation. Results. HLA-A2+ allografts transplanted into C57BL/6, CD8-KO, and Ig-KO mice demonstrated OAD lesions by day 30. In contrast, allografts transplanted into CD4-KO mice showed no OAD lesions at day 30, partial OAD development by days 60 and 90, and complete OAD development by day 180. No OAD development was observed in allografts transplanted into Rag1-KO mice. Treatment with anti-NK1.1 antibody did not show any effect on posttransplant OAD development. In contrast, anti-CD4+ or anti-CD8+ antibody treatments partially reduced the OAD histopathology and combined anti-CD4/CD8 antibody treatment further abrogated the histopathology of the disease. Conclusion. These results show that both CD4+ and CD8+ T cells have a role in the pathogenesis of OAD and that natural killer cells and alloantibodies are not necessary for the development of this disease.Keywords
This publication has 19 references indexed in Scilit:
- Indirect Allorecognition of Mismatched Donor HLA Class II Peptides in Lung Transplant Recipients with Bronchiolitis Obliterans SyndromeAmerican Journal of Transplantation, 2001
- INDIRECT RECOGNITION OF DONOR HLA CLASS I PEPTIDES IN LUNG TRANSPLANT RECIPIENTS WITH BRONCHIOLITIS OBLITERANS SYNDROME1Transplantation, 1999
- DEVELOPMENT OF ELISA-DETECTED ANTI-HLA ANTIBODIES PRECEDES THE DEVELOPMENT OF BRONCHIOLITIS OBLITERANS SYNDROME AND CORRELATES WITH PROGRESSIVE DECLINE IN PULMONARY FUNCTION AFTER LUNG TRANSPLANTATION1Transplantation, 1999
- Persistent allopeptide reactivity and epitope spreading in chronic rejection of organ allografts.Journal of Clinical Investigation, 1998
- INDIRECT ALLORECOGNITION OF MAJOR HISTOCOMPATIBILITY COMPLEX ALLOPEPTIDES IN HUMAN RENAL TRANSPLANT RECIPIENTS WITH CHRONIC GRAFT DYSFUNCTION1Transplantation, 1997
- OBLITERATIVE BRONCHIOLITISClinics in Chest Medicine, 1997
- Indirect recognition of donor HLA-DR peptides in organ allograft rejection.Journal of Clinical Investigation, 1996
- Indirect Recognition of Donor MHC Class II Antigens in Human TransplantationClinical Immunology and Immunopathology, 1996
- BOTH ALLOANTIGEN-DEPENDENT AND -INDEPENDENT FACTORS INFLUENCE CHRONIC ALLOGRAFT REJECTIONTransplantation, 1995
- The Molecular Basis of AllorecognitionAnnual Review of Immunology, 1993